Luminar (LAZR) 10-Q 9 May 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	Apr. 28, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-38791
Entity Registrant Name	Luminar Technologies, Inc./DE
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-1804317
Entity Address, Address Line One	2603 Discovery Drive
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32826
City Area Code	407
Local Phone Number	900-5259
Title of 12(b) Security	Class A common stock, par value of $0.0001 per share
Trading Symbol	LAZR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001758057
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		280,568,075
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		97,088,670

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 89,933	$ 69,552
Restricted cash	2,226	1,553
Marketable securities	332,363	419,314
Accounts receivable	21,051	11,172
Inventory	14,918	8,792
Prepaid expenses and other current assets	33,859	44,203
Total current assets	494,350	554,586
Property and equipment, net	78,395	30,260
Operating lease right-of-use assets	20,986	21,244
Intangible assets, net	29,255	22,077
Goodwill	19,879	18,816
Other non-current assets	15,486	40,344
Total assets	658,351	687,327
Current liabilities:
Accounts payable	29,916	18,626
Accrued and other current liabilities	64,662	52,962
Operating lease liabilities	5,906	5,953
Total current liabilities	100,484	77,541
Warrant liabilities	4,059	3,005
Convertible senior notes	613,001	612,192
Operating lease liabilities, non-current	17,061	16,989
Other non-current liabilities	6,026	4,005
Total liabilities	740,631	713,732
Commitments and contingencies (Note 14)
Stockholders’ deficit:
Additional paid-in capital	1,647,357	1,558,685
Accumulated other comprehensive loss	(2,000)	(4,226)
Treasury stock	(312,477)	(312,477)
Accumulated deficit	(1,415,200)	(1,268,426)
Total stockholders’ deficit	(82,280)	(26,405)
Total liabilities and stockholders’ deficit	658,351	687,327
Class A common stock
Stockholders’ deficit:
Common stock	30	29
Class B common stock
Stockholders’ deficit:
Common stock	$ 10	$ 10

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total revenue	$ 14,509	$ 6,855
Total cost of sales	29,133	16,654
Gross loss	(14,624)	(9,799)
Operating expenses:
Research and development	69,052	33,109
Sales and marketing	13,729	9,398
General and administrative	44,490	30,025
Total operating expenses	127,271	72,532
Loss from operations	(141,895)	(82,331)
Change in fair value of warrant liabilities	(1,054)	(3,857)
Interest expense	(1,665)	(3,280)
Interest income	1,905	1,071
Other income (expense)	(4,065)	468
Total other income (expense), net	(4,879)	(5,598)
Loss before provision for income taxes	(146,774)	(87,929)
Provision for income taxes	0	404
Net loss	$ (146,774)	$ (88,333)
Net loss per share:
Basic (in dollars per share)	$ (0.40)	$ (0.25)
Diluted (in dollars per share)	$ (0.40)	$ (0.25)
Shares used in computing net loss per share:
Basic (in shares)	370,742,917	348,683,836
Diluted (in shares)	370,742,917	348,683,836
Comprehensive Income (Loss):
Net loss	$ (146,774)	$ (88,333)
Net unrealized gain (loss) on available-for-sale debt securities	2,226	(3,648)
Comprehensive income (loss)	(144,548)	(91,981)
Products
Total revenue	7,367	1,541
Total cost of sales	19,203	11,818
Services
Total revenue	7,142	5,314
Total cost of sales	$ 9,930	$ 4,836

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Equity Financing Program	Additional Paid-in Capital	Additional Paid-in Capital Equity Financing Program	Accumulated Other Comprehensive Loss	Treasury Stock	Accumulated Deficit	Class A Common Stock	Class A Common Stock Equity Financing Program	Class A Common Stock Common Stock	Class A Common Stock Common Stock Equity Financing Program	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2021										266,076,525			97,088,670
Beginning balance at Dec. 31, 2021	$ 197,985		$ 1,257,214		$ (908)	$ (235,871)	$ (822,487)			$ 27			$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(39,648)					(39,648)
Issuance of Class A common stock upon exercise of warrants (in shares)										401,365
Issuance of Class A common stock upon exercise of warrants	18,689		18,689
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)										2,117,059
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	1,085		1,085
Retirement of unvested restricted common stock (in shares)										(40,763)
Vendor payments under the stock-in-lieu of cash program (in shares)										1,424,350
Vendor payments under the stock-in-lieu of cash program	14,613		14,613
Share-based compensation	23,657		23,657
Payments of employee taxes related to vested restricted stock units	(516)		(516)
Other comprehensive income (loss)	(3,648)				(3,648)
Net loss	(88,333)						(88,333)
Ending balance (in shares) at Mar. 31, 2022										269,978,536			97,088,670
Ending balance at Mar. 31, 2022	123,884		1,314,742		(4,556)	(275,519)	(910,820)			$ 27			$ 10
Beginning balance (in shares) at Dec. 31, 2022										291,942,087			97,088,670
Beginning balance at Dec. 31, 2022	(26,405)		1,558,685		(4,226)	(312,477)	(1,268,426)			$ 29			$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)										4,715,737	2,759,689
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	1,039	$ 22,665	1,038	$ 22,665					$ 22,700	$ 1
Vendor payments under the stock-in-lieu of cash program (in shares)										1,627,690
Vendor payments under the stock-in-lieu of cash program	16,741		16,741
Share-based compensation	48,800		48,800
Payments of employee taxes related to vested restricted stock units	(572)		(572)
Other comprehensive income (loss)	2,226				2,226
Net loss	(146,774)						(146,774)
Ending balance (in shares) at Mar. 31, 2023								279,181,753		301,045,203		97,088,670	97,088,670
Ending balance at Mar. 31, 2023	$ (82,280)		$ 1,647,357		$ (2,000)	$ (312,477)	$ (1,415,200)			$ 30			$ 10

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (146,774)	$ (88,333)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,987	805
Amortization of operating lease right-of-use assets	1,610	885
Amortization of premium (discount) on marketable securities	(743)	444
Loss on marketable securities	3,033	0
Change in fair value of private warrants	1,054	3,857
Vendor stock-in-lieu of cash program	5,684	7,848
Amortization of debt discount and issuance costs	809	809
Inventory write-offs and write-downs	5,451	1,356
Share-based compensation	55,954	26,698
Product warranty and other	586	107
Changes in operating assets and liabilities:
Accounts receivable	(9,877)	9,757
Inventories	(11,578)	(768)
Prepaid expenses and other current assets	9,932	(3,300)
Other non-current assets	(4,156)	158
Accounts payable	11,191	5,983
Accrued and other current liabilities	11,651	1,200
Other non-current liabilities	(1,488)	(343)
Net cash used in operating activities	(64,674)	(32,837)
Cash flows from investing activities:
Acquisition of Seagate’s lidar business	(12,608)	0
Purchases of marketable securities	(81,623)	(193,687)
Proceeds from maturities of marketable securities	148,345	91,454
Proceeds from sales/redemptions of marketable securities	20,165	12,842
Purchases of property and equipment	(11,680)	(5,004)
Net cash provided by (used in) investing activities	62,599	(94,395)
Cash flows from financing activities:
Net proceeds from issuance of Class A common stock under the Equity Financing Program	22,665	0
Proceeds from exercise of stock options	1,036	1,092
Payments of employee taxes related to stock-based awards	(572)	(516)
Repurchase of common stock	0	(43,920)
Net cash provided by (used in) financing activities	23,129	(43,344)
Net increase (decrease) in cash, cash equivalents and restricted cash	21,054	(170,576)
Beginning cash, cash equivalents and restricted cash	71,105	330,702
Ending cash, cash equivalents and restricted cash	92,159	160,126
Supplemental disclosures of noncash investing and financing activities:
Issuance of Class A common stock upon exercise of warrants	0	18,689
Operating lease right-of-use assets obtained in exchange for lease obligations	1,211	5,746
Purchases of property and equipment recorded in accounts payable and accrued liabilities	7,978	1,950
Vendor stock-in-lieu of cash program—advances for capital projects and equipment	$ 2,520	$ 0

Organization and Description of

Organization and Description of Business	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Luminar Technologies, Inc. (together with its wholly-owned subsidiaries, the “Company” or “Luminar”) was incorporated in Delaware. Luminar is a global automotive technology company ushering in a new era of vehicle safety and autonomy. Over the past decade, Luminar has been building from the chip-level up, its light detection and ranging sensor, or lidar, which is expected to meet the demanding performance, safety, reliability and cost requirements to enable next generation safety and autonomous capabilities for passenger and commercial vehicles as well as other adjacent markets.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Annual Report”) filed with the SEC on February 28, 2023. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory reserves, valuation allowance for deferred tax assets, valuation of warrants issued in a private placement in connection with the initial public offering of Gores Metropoulos, Inc. (the Company’s former name) (“Private Warrants”), valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates. Segment Information The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments: (i) “Autonomy Solutions,” which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In January 2023, the Company acquired certain assets from Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd. (individually and collectively, “Seagate”). Assets purchased from Seagate have been included in the Autonomy Solutions segment. (ii) “Advanced Technologies and Services” (“ATS”), which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits. Concentration of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s deposits exceed federally insured limits. Cash held by foreign subsidiaries of the Company as of March 31, 2023 and December 31, 2022 was not material. The Company’s revenue is derived from customers located in the United States and international markets. Three customers accounted for 33%, 23% and 17% of the Company’s accounts receivable as of March 31, 2023. Three customers accounted for 27%, 23% and 11% of the Company’s accounts receivable as of December 31, 2022. Significant Accounting Policies The Company’s significant accounting policies are disclosed in its Annual Report on Form 10-K for the year ended December 31, 2022. There has been no material change to the Company’s significant accounting policies during the three months ended March 31, 2023. Recent Accounting Pronouncements Not Yet Effective The Company has reviewed, or is in the process of evaluating, all issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such accounting pronouncements will cause a material impact on its consolidated financial position, operating results or statements of cash flows.

Business Combinations and Acqui

Business Combinations and Acquisitions	3 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations and Acquisitions	Business Combinations and Acquisitions Acquisition of Seagate’s Lidar Business On January 18, 2023, the Company acquired certain assets (including intellectual property (“IP”), equipment and other assets) and employees from Seagate Technology LLC and its affiliates (together “Seagate”). The Company simultaneously licensed IP from Seagate. The aggregate purchase price of $12.6 million for the said acquired assets and the license was paid in cash. The acquired assets and employees comprised Seagate’s lidar development operations and have been combined into the Company’s research and development team. This transaction has been accounted for as a business combination. Recording of Assets Acquired and Liabilities Assumed Price allocation includes preliminary estimates of fair value of certain working capital and deferred tax balances. Preliminary estimates of fair values included in the condensed consolidated financial statements are expected to be finalized within a one-year measurement period following the acquisition date after which any subsequent adjustments will be reflected in the consolidated statements of operations. The following table summarizes the preliminary purchase price allocation to assets acquired (in thousands): Preliminary Recorded Value Property plant and equipment $ 3,163 Developed Technology (1) 8,240 Goodwill (2) 1,063 Other assets 142 Net assets acquired $ 12,608 (1) Technology and IP Licenses were measured using the cost approach. Significant inputs used as part of the valuation of intangible assets include personnel costs, overhead costs, developer’s profit, and expected time to reproduce. (2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included workforce and expected synergies derived from the technology application to the Company’s current technological platforms. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the Autonomy Solutions segment, which is also deemed the reporting unit. Identifiable intangible assets recognized (in thousands): Useful Life Preliminary Recorded Value Developed technology 4 — 6 years $ 8,240 The acquired business did not contribute distinct revenues but added additional operating expenses primarily related to personnel-related costs of the hired team of former Seagate employees and related facilities costs in the period from January 18, 2023 to March 31, 2023. Such operating expenses were not material to the operating results of the Company for the three months ended March 31, 2023.

Revenue

Revenue	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The Company’s revenue is comprised of sales of lidar sensors hardware, components, NRE services and licensing of certain information available with the Company. Disaggregation of Revenues The Company disaggregates its revenue from contracts with customers by (1) geographic region based on a customer’s billed to location, and (2) type of good or service and timing of transfer of goods or services to customers (point-in-time or over time), as it believes it best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands): Three Months Ended March 31, 2023 2022 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 13,198 91 % $ 4,968 73 % Asia Pacific 592 4 % 1,860 27 % Europe and Middle East 719 5 % 27 — % Total $ 14,509 100 % $ 6,855 100 % Revenue by timing of recognition: Recognized at a point in time $ 7,358 51 % $ 1,541 22 % Recognized over time 7,151 49 % 5,314 78 % Total $ 14,509 100 % $ 6,855 100 % Revenue by segment: Autonomy Solutions $ 10,673 74 % $ 5,898 86 % ATS 3,836 26 % 957 14 % Total $ 14,509 100 % $ 6,855 100 % Volvo Stock Purchase Warrant As disclosed in the Company’s 2022 Annual Report, the Company had previously issued certain stock purchase warrants (“Volvo Warrants”) to Volvo Car Technology Fund AB (“VCTF”) in connection with an engineering services contract. The Volvo Warrants vest and become exercisable in two tranches based on satisfaction of certain commercial milestones. The fair value of the first tranche of the Volvo Warrants was recorded as a reduction in revenue in 2021. The second tranche of the Volvo warrants will be recorded as reduction in revenue upon achievement of sales of a certain number of the Company’s sensors to Volvo for use in their commercial vehicles, which had not commenced as of the end of March 31, 2023. Contract assets and liabilities Contract assets primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. Contract liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized related to product sales and other services revenue and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent required customer payments in advance of product shipments according to the customer’s payment term. Customer advance payments are recognized in revenue as or when control of the performance obligation is transferred to the customer. The opening and closing balances of contract assets were as follows (in thousands): March 31, 2023 December 31, 2022 Contract assets, current $ 7,904 $ 15,395 Contract assets, non-current 5,985 2,575 Ending balance $ 13,889 $ 17,970 The significant changes in contract assets balances consisted of the following (in thousands): March 31, 2023 December 31, 2022 Beginning balance $ 17,970 $ 9,907 Amounts billed that were included in the contract assets beginning balance (8,414) (4,228) Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 4,333 12,291 Ending balance $ 13,889 $ 17,970 The opening and closing balances of contract liabilities were as follows (in thousands): March 31, 2023 December 31, 2022 Contract liabilities, current $ 4,558 $ 1,993 Contract liabilities, non-current 414 1,015 Ending balance $ 4,972 $ 3,008 The significant changes in contract liabilities balances consisted of the following (in thousands): March 31, 2023 December 31, 2022 Beginning balance $ 3,008 $ 898 Revenue recognized that was included in the contract liabilities beginning balance (1,492) (489) Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 3,456 2,599 Ending balance $ 4,972 $ 3,008 Remaining Performance Obligations Revenue allocated to remaining performance obligations was $37.7 million as of March 31, 2023 and includes amounts within contract liabilities. The Company expects to recognize approximately 83% of this revenue over the next 12 months and the remainder thereafter.

Investments

Investments	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Debt Securities The Company’s investments in debt securities consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Cost Gross Gross Fair Value U.S. treasury securities $ 228,254 $ 27 $ (1,392) $ 226,889 U.S. agency and government sponsored securities 5,000 — (25) 4,975 Commercial paper 27,286 — (84) 27,202 Corporate bonds 73,411 — (493) 72,918 Asset-backed securities 4,523 — (33) 4,490 Total debt securities $ 338,474 $ 27 $ (2,027) $ 336,474 Included in cash and cash equivalents $ 29,828 $ 2 $ (3) $ 29,827 Included in marketable securities 308,646 25 (2,024) 306,647 December 31, 2022 Cost Gross Gross Fair Value U.S. treasury securities $ 191,075 $ 3 $ (2,598) $ 188,480 U.S. agency and government sponsored securities 4,999 — (75) 4,924 Commercial paper 74,755 — (232) 74,523 Corporate bonds 111,123 — (1,214) 109,909 Asset-backed securities 11,945 — (110) 11,835 Total debt securities $ 393,897 $ 3 $ (4,229) $ 389,671 Included in marketable securities $ 393,897 $ 3 $ (4,229) $ 389,671 The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 December 31, 2022 Gross Fair Value Gross Fair Value U.S. treasury securities $ (1,392) $ 174,013 $ (2,598) $ 158,888 U.S. agency and government sponsored securities (25) 4,975 (75) 4,924 Commercial paper (84) 27,202 (232) 74,523 Corporate bonds (493) 72,918 (1,214) 109,909 Asset-backed securities (33) 4,490 (110) 11,835 Total $ (2,027) $ 283,598 $ (4,229) $ 360,079 As of March 31, 2023, the total amortized cost basis of the Company’s available-for-sale securities exceeded its fair value by $2.0 million, which was primarily attributable to widening credit spreads and rising interest rates since purchase. The Company reviewed its available-for-sale securities and concluded that the decline in fair value was not related to credit losses and that it is more likely than not that the entire amortized cost of each security will be recoverable before the Company is required to sell them or when the security matures. Accordingly, during the three months ended March 31, 2023, no allowance for credit losses was recorded and instead the unrealized losses are reported as a component of accumulated other comprehensive income (loss). Equity Investments The Company’s equity investments consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands): Condensed Consolidated Balance Sheets Location March 31, 2023 December 31, 2022 Money market funds (1) Cash and cash equivalents $ 34,202 $ 42,056 Marketable equity investments (1) Marketable securities 25,716 29,643 Non-marketable equity investment measured using the measurement alternative (2) Other non-current assets 4,000 4,000 Total $ 63,918 $ 75,699 (1) Investments with readily determinable fair values. (2) Investment in privately held company without readily determinable fair value. The Company assesses its non-marketable equity investments quarterly for impairment. Adjustments and impairments are recorded in other income (expense), net on the condensed consolidated statements of operations.

Financial Statement Components

Financial Statement Components	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Financial Statement Components	Financial Statement Components Cash and Cash Equivalents Cash and cash equivalents consisted of the following (in thousands): March 31, 2023 December 31, 2022 Cash $ 25,904 $ 27,496 Money market funds 34,202 42,056 U.S. treasury securities 29,827 — Total cash and cash equivalents $ 89,933 $ 69,552 Inventory Inventory comprised of the following (in thousands): March 31, 2023 December 31, 2022 Raw materials $ 8,066 $ 3,614 Work-in-process 3,706 2,329 Finished goods 3,146 2,849 Total inventories, net $ 14,918 $ 8,792 The Company’s inventory write-offs and write-downs (primarily due to obsolescence, lower of cost or market assessment, and other adjustments) was $5.5 million and $1.4 million for the three months ended March 31, 2023 and 2022, respectively. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Prepaid expenses $ 14,729 $ 15,653 Contract assets 7,904 15,395 Advance payments to vendors 5,394 7,919 Other receivables 5,832 5,236 Total prepaid expenses and other current assets $ 33,859 $ 44,203 Property and Equipment Property and equipment consisted of the following (in thousands): March 31, 2023 December 31, 2022 Machinery and equipment $ 25,817 $ 14,047 Computer hardware and software 7,978 6,797 Land 1,001 1,001 Leasehold improvements 19,359 885 Vehicles, including demonstration fleet 3,357 3,222 Furniture and fixtures 817 818 Construction in progress 32,143 13,642 Total property and equipment 90,472 40,412 Accumulated depreciation and amortization (12,077) (10,152) Total property and equipment, net $ 78,395 $ 30,260 Property and equipment capitalized under finance lease (capital lease prior to adoption of ASC 842) were not material. Construction in progress increased due to increased capital expenditure related to build out of series production equipment and facilities, which are expected to be completed over approximately next 12 months. Depreciation and amortization expense associated with property and equipment was $1.9 million and $0.7 million for the three months ended March 31, 2023 and 2022, respectively. Intangible Assets The following table summarizes the activity in the Company’s intangible assets (in thousands): March 31, 2023 December 31, 2022 Beginning of the period $ 22,077 $ 2,424 Additions 8,240 21,890 Amortization (1,062) (2,237) End of the period $ 29,255 $ 22,077 The components of intangible assets were as follows (in thousands): March 31, 2023 December 31, 2022 Gross Accumulated Net Weighted Average Gross Accumulated Net Weighted Customer relationships $ 3,730 $ (867) $ 2,863 4.2 $ 3,730 $ (664) $ 3,066 4.4 Customer backlog 650 (390) 260 0.7 650 (292) 358 0.9 Tradename 620 (245) 375 3.0 620 (214) 406 3.3 Assembled workforce 130 (130) — — 130 (130) — — Developed technology 20,150 (1,893) 18,257 6.3 11,910 (1,163) 10,747 7.5 IPR&D 7,500 — 7,500 — 7,500 — 7,500 — Total intangible assets $ 32,780 $ (3,525) $ 29,255 5.9 $ 24,540 $ (2,463) $ 22,077 6.6 Amortization expense related to intangible assets was $1.1 million and $0.1 million for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future 2023 (remaining nine months) $ 3,261 2024 4,001 2025 4,001 2026 3,354 2027 3,138 Thereafter 4,000 IPR&D 7,500 Total $ 29,255 Goodwill The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands): Autonomy Solutions ATS Total Balance as of December 31, 2022 $ 687 $ 18,129 $ 18,816 Goodwill related to acquisition of Seagate’s lidar business (see Note 3) 1,063 — 1,063 Balance as of March 31, 2023 $ 1,750 $ 18,129 $ 19,879 Other Non-Current Assets Other non-current assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Security deposits $ 5,078 $ 5,495 Non-marketable equity investment 4,000 4,000 Advance payment for capital projects — 27,683 Contract assets 5,985 2,575 Other non-current assets 423 591 Total other non-current assets $ 15,486 $ 40,344 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following (in thousands): March 31, 2023 December 31, 2022 Accrued compensation and benefits $ 21,639 $ 16,682 Accrued expenses 24,592 22,358 Warranty reserves 4,170 3,584 Contract liabilities 4,558 1,993 Accrued interest payable 2,286 359 Contract losses 6,890 7,526 Other 527 460 Total accrued and other current liabilities $ 64,662 $ 52,962 During the three months ended March 31, 2023 and 2022, the Company recorded $3.3 million and $0.4 million, respectively, in cost of sales (services) estimated losses expected to be incurred on NRE projects with certain customers. The estimated contract losses recorded were primarily a result of (a) changes in estimates related to costs expected to be incurred for contractual milestones based on actual experience on similar projects and (b) changes in scope of project deliverables agreed upon with the respective customers during the year.

Convertible Senior Notes and Ca

Convertible Senior Notes and Capped Call Transactions	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes and Capped Call Transactions	Convertible Senior Notes and Capped Call Transactions In December 2021, the Company issued $625.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2026 in a private placement, which included $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the option granted to the initial purchasers to purchase additional notes (collectively, the “Convertible Senior Notes”). The interest on the Convertible Senior Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2022. The Convertible Senior Notes will mature on December 15, 2026, unless repurchased or redeemed earlier by the Company or converted pursuant to their terms. The total net proceeds from the debt offering, after deducting fees paid to the initial purchasers paid by the Company, was approximately $609.4 million. Each $1,000 principal amount of the Convertible Senior Notes is initially convertible into 50.0475 shares of the Company’s Class A common stock, par value $0.0001, which is equivalent to an initial conversion price of approximately $19.98 per share. The conversion rate is subject to adjustment upon the occurrence of certain specified events prior to the maturity date but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if the Company delivers a notice of redemption in respect of some or all of the Convertible Senior Notes, the Company will, under certain circumstances, increase the conversion rate of the Convertible Senior Notes for a holder who elects to convert its Convertible Senior Notes in connection with such a corporate event or convert its Convertible Senior Notes called for redemption during the related redemption period, as the case may be. The Convertible Senior Notes are redeemable, in whole or in part (subject to certain limitations), at the Company’s option at any time, and from time to time, on or after December 20, 2024, and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, but only if certain liquidity conditions are satisfied and the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice, and (2) the trading day immediately before the date the Company sends such notice. If the Company undergoes a fundamental change (as defined in the indenture governing the Convertible Senior Notes) prior to the maturity date, holders may require the Company to repurchase for cash all or any portion of their Convertible Senior Notes in principal amounts of $1,000 or a multiple thereof at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. Holders of the Convertible Senior Notes may convert their Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding December 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March 31, 2022, if the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Class A common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of specified corporate events or distributions on the Class A common stock; and (4) if the Convertible Senior Notes are called for redemption. On or after June 15, 2026, holders may convert all or any portion of their Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its Class A common stock or a combination of cash and shares of its Class A common stock, at the Company’s election. As of March 31, 2023, the conditions allowing holders of the Convertible Senior Notes to convert were not met. The Company currently intends to settle the principal amount of its outstanding Convertible Senior Notes in cash and any excess in shares of the Company’s Class A common stock. The Convertible Senior Notes are senior unsecured obligations and will rank equal in right of payment with the Company’s future senior unsecured indebtedness; senior in right of payment to the Company’s future indebtedness that is expressly subordinated to the Convertible Senior Notes; effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries. The Company has classified the Convertible Senior Notes as a non-current liability under the guidance in ASC 470-20, as amended by ASU 2020-06. Debt discount and issuance costs aggregating approximately $16.2 million were initially recorded as a reduction to the principal amount of the Convertible Senior Notes and is being amortized as interest expense on a straight line basis over the contractual terms of the notes. The Company estimates that the difference between amortizing the debt discounts and the issuance costs using the straight line method as compared to using the effective interest rate method is immaterial. The net carrying amount of the Convertible Senior Notes was as follows (in thousands): March 31, 2023 December 31, 2022 Principal $ 625,000 $ 625,000 Unamortized debt discount and issuance costs (11,999) (12,808) Net carrying amount $ 613,001 $ 612,192 The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands): Three Months Ended March 31, 2023 2022 Contractual interest expense $ 1,926 $ 1,926 Amortization of debt discount and issuance costs 809 809 Total interest expense $ 2,735 $ 2,735 The remaining term over which the debt discount and issuance costs will be amortized is 3.71 years. Interest expense of $1.9 million and $1.9 million is reflected as a component of interest (expense) income, net in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2023 and 2022, respectively. In connection with the offering of the Convertible Senior Notes, the Company entered into privately negotiated capped call option transactions with certain counterparties (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $19.98 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Convertible Senior Notes. The Capped Calls have initial cap prices of $30.16 per share, subject to certain adjustment events. The Capped Calls are generally intended to reduce the potential dilution to the Class A common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Convertible Senior Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. The Capped Calls expire on April 6, 2027, subject to earlier exercise. The Capped Calls are subject to either adjustment or termination upon the occurrence of specified extraordinary events affecting the Company, including a merger event, a tender offer, and a nationalization, insolvency or delisting involving the Company. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including changes in law, failure to deliver, and hedging disruptions. The Capped Calls are recorded in stockholders’ equity and are not accounted for as derivatives. The net cost of $73.4 million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in the accompanying consolidated balance sheet.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements As of March 31, 2023, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded. Given that the transfer of Private Warrants to anyone outside of a small group of individuals constituting the sponsors of Gores Metropoulos, Inc. would result in the Private Warrants having substantially the same terms as the Public Warrants, management determined that the fair value of each Private Warrant is the same as that of a Public Warrant, with an insignificant adjustment for short-term marketability restrictions, as of December 31, 2022. As of March 31, 2023, management determined the fair value of the Private Warrants using observable inputs in the Black-Scholes valuation model, which used the remaining term of warrants of 2.68 years, volatility of 81.1% and a risk-free rate of 3.89%. Accordingly, the Private Warrants are classified as Level 3 financial instruments. The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands): Private Warrants Balance as of December 31, 2022 $ 3,005 Change in fair value of outstanding warrants 1,054 Balance as of March 31, 2023 $ 4,059 The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): Fair Value (in thousands) Measured as of March 31, 2023 Using: Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 34,202 $ — $ — $ 34,202 U.S. treasury securities 29,827 — — 29,827 Total cash equivalents $ 64,029 $ — $ — $ 64,029 Marketable investments: U.S. treasury securities $ 197,062 $ — $ — $ 197,062 U.S. agency and government sponsored securities — 4,975 — 4,975 Commercial paper — 27,202 — 27,202 Corporate bonds — 72,918 — 72,918 Asset-backed securities — 4,490 — 4,490 Marketable equity investments 25,716 — — 25,716 Total marketable investments $ 222,778 $ 109,585 $ — $ 332,363 Liabilities: Private Warrants $ — $ — $ 4,059 $ 4,059 Fair Value (in thousands) Measured as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 42,056 $ — $ — $ 42,056 Total cash equivalents $ 42,056 $ — $ — $ 42,056 Marketable investments: U.S. treasury securities $ 188,480 $ — $ — $ 188,480 U.S. agency and government sponsored securities — 4,924 — 4,924 Commercial paper — 74,523 — 74,523 Corporate bonds — 109,909 — 109,909 Asset-backed securities — 11,835 — 11,835 Marketable equity investments 29,643 — — 29,643 Total marketable investments $ 218,123 $ 201,191 $ — $ 419,314 Liabilities: Private Warrants $ — $ — $ 3,005 $ 3,005 The Company’s non-marketable equity investment, measured at fair value on a non-recurring basis, is classified within Level 3 in the fair value hierarchy because the Company estimated the value based on valuation methods which included unobservable inputs including projections received from Robotic Research, market conditions, preference rights, etc. of the investment the Company holds. See Note 5 for further information on the Company’s non-marketable equity investment. As of March 31, 2023 and December 31, 2022, the estimated fair value of the Company’s outstanding Convertible Senior Notes was $416.9 million and $352.5 million, respectively. The fair value was determined based on the quoted price of the Convertible Senior Notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 7 for further information on the Company’s Convertible Senior Notes. The fair value of Company’s other financial instruments, including accounts receivable, accounts payable and other current liabilities, approximate their carrying value due to the relatively short maturity of those instruments. The carrying amounts of the Company’s finance leases approximate their fair value, which is the present value of expected future cash payments based on assumptions about current interest rates and the creditworthiness of the Company.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Earnings (Loss) Per Share Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock during the period plus common stock equivalents, as calculated under the treasury stock method, outstanding during the period. If the Company reports a net loss, the computation of diluted loss per share excludes the effect of dilutive common stock equivalents, as their effect would be antidilutive. The Company computes earnings (loss) per share using the two-class method for its Class A and Class B common stock. Earnings (loss) per share is same for both Class A and Class B common stock since they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per share for the three months ended March 31, 2023 and 2022 (in thousands, except for share and per share amounts): Three Months Ended March 31, 2023 2022 Numerator: Net loss $ (146,774) $ (88,333) Denominator: Weighted average common shares outstanding—Basic 370,742,917 348,683,836 Weighted average common shares outstanding—Diluted 370,742,917 348,683,836 Net loss per share attributable to common shareholders—Basic and Diluted $ (0.40) $ (0.25) The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive or related contingencies on issuance of shares had not been met as of March 31, 2023: March 31, 2023 Warrants 5,757,549 Stock-based awards—Equity classified 36,303,214 Stock-based awards—Liability classified 11,365,535 Vendor stock-in-lieu of cash program 816,705 Convertible Senior Notes 31,279,716 Earn-out shares 8,606,717 Total 94,129,436

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Class A and Class B Common Stock The Company’s board of directors (the “Board”) has authorized two classes of common stock, Class A and Class B. As of March 31, 2023, the Company had authorized 715,000,000 shares of Class A common stock and 121,000,000 shares of Class B common stock with a par value of $0.0001 per share for each class. As of March 31, 2023, the Company had 301,045,203 shares issued and 279,181,753 shares outstanding of Class A common stock, and 97,088,670 shares issued and outstanding of Class B common stock. Holders of Class A and Class B common stock have identical rights, except that holders of the Class A common stock are entitled to one vote per share and the holder of the Class B common stock is entitled to ten votes per share. Equity Financing Program On February 28, 2023, the Company entered into an agreement (the “Sales Agreement”) with Virtu Americas LLC (the “Agent”) under which the Company may offer and sell, from time to time in its sole discretion, shares of the Company’s Class A common stock with aggregate gross sales proceeds of up to $75.0 million through an equity offering program under which the Agent will act as sales agent (the “Equity Financing Program”). The Company intends to use the net proceeds from offerings under the Equity Financing Program primarily for expenditures or payments in connection with strategic merger and acquisition opportunities, as well as potential strategic investments, partnerships and similar transactions. Under the Sales Agreement, the Company sets the parameters for the sale of the shares, including the number of shares to be issued, the time period during which sales are requested to be made, limitations on the number of shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the terms and conditions of the Sales Agreement, the Agent has agreed to use its commercially reasonable efforts, consistent with its normal trading and sales practices, to sell the shares by methods deemed to be an “at the market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including sales made through The Nasdaq Global Select Market. The Company issued 2,759,689 shares of Class A common stock under the Equity Financing Program during the three months ended March 31, 2023 for net proceeds of $22.7 million. As of March 31, 2023, $52.1 million of Class A common stock was available for sale under the program. Private Warrants The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. No Private Warrants were exercised in the three months ended March 31, 2023. The Private Warrants are set to expire on December 2, 2025. Each Private Warrant allows the holder to purchase one share of Class A common stock at $11.50 per share. Stock-in-lieu of Cash Program The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors / third parties for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). The Company considers the shares issuable under the Stock-in-lieu of Cash Program as liability classified awards when the arrangement with the vendors requires the Company to issue a variable number of shares to settle amounts owed. During the three months ended March 31, 2023, the Company issued 1,627,690 shares of Class A common stock as part of the Stock-in-lieu of Cash Program, including 1,564,822 shares of Class A common stock in lieu of cash to a certain vendor for purchases of certain hardware, software and data labeling services pursuant to a private placement. As of March 31, 2023, the Company had a total of $11.6 million in prepaid expenses and other current and non-current assets related to its Stock-in-lieu of Cash Program. The Company’s vendor Stock-in-lieu of Cash Program activity for the three months ended March 31, 2023 was as follows: Shares Weighted Average Unvested shares as of December 31, 2022 1,047,151 $ 11.90 Granted 1,627,690 6.43 Vested (1,976,031) 7.02 Unvested shares as of March 31, 2023 698,810 12.96

Stock-based Compensation

Stock-based Compensation	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation Prior to becoming a publicly traded entity, the Company issued incentive stock options, non-qualified stock options, and restricted stock to employees and non-employee consultants under its 2015 Stock Plan (the “2015 Plan”). Since the closing of the business combination between Gores Metropoulos, Inc. and Luminar Technologies, Inc. on December 2, 2020 (the “Business Combination”), the Company has not issued any new stock-based awards under the 2015 Plan. In December 2020, the Board adopted and the Company’s stockholders approved the 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan became effective upon the closing of the Business Combination. Under the 2020 Plan, the Company was originally authorized to issue a maximum number of 36,588,278 shares of Class A common stock. In June 2022, the Company’s stockholders approved an amendment and restatement of the Company’s 2020 Plan (the “Amended 2020 Plan”) to increase the number of shares of Class A common stock authorized for issuance by 36,000,000 additional shares and added an evergreen provision under which the number of shares of Class A common stock available for issuance under the Amended 2020 Plan will be increased on the first day of each fiscal year of the Company beginning with the 2023 fiscal year and ending on (and including) the first day of the 2030 fiscal year, in an amount equal to the lesser of (i) 5% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, (ii) 40,000,000 shares or (iii) such number of shares determined by the Board. Pursuant to the evergreen provision, 18,358,365 additional shares of Class A common stock were added to the Amended 2020 Plan on January 1, 2023. Stock Options Under the terms of the 2015 Plan, incentive stock options had an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options were permitted to be granted below fair market value of the stock on the date of grant. Stock options granted have service-based vesting conditions only. The service-based vesting conditions vary, though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a 10-year period to exercise their options before they expire. Forfeitures are recognized in the period of occurrence. The Company’s stock option activity for the three months ended March 31, 2023 was as follows: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2022 8,162,850 $ 1.74 Exercised (622,042) 1.67 Cancelled/Forfeited (155,430) 1.67 Outstanding as of March 31, 2023 7,385,378 1.74 6.73 $ 35,694 The aggregate intrinsic value of stock options exercised during the three months ended March 31, 2023 was $3.8 million. The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the exercise date. The total grant-date fair value of the options vested was $1.1 million during the three months ended March 31, 2023. Restricted Stock Awards Prior to June 30, 2019, the Company granted restricted stock awards (“RSAs”) to employees. Recipients purchased the restricted stock on the grant date and the Company has the right to repurchase the restricted shares at the same price recipients paid to obtain those shares. The restrictions lapse solely based on continued service, and generally lapse over 4 years —25% on the first anniversary of the date of issuance, and the remaining 75% monthly over the remaining 36 months. At the grant date of the award, recipients of restricted stock are granted voting rights and receive dividends on unvested shares. No restricted stock awards have been granted after June 30, 2019. The Company’s RSAs activity for the three months ended March 31, 2023 was as follows: Shares Weighted Average Outstanding as of December 31, 2022 64,486 $ 1.29 Vested (52,826) 1.30 Outstanding as of March 31, 2023 11,660 1.29 Restricted Stock units Since the closing of the Business Combination, the Company has granted restricted stock units (“RSUs”) under the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan). Each RSU granted under the Amended 2020 Plan represents a right to receive one share of the Company’s Class A common stock when the RSU vests. RSUs generally vest over a period up to six years. The Company has granted certain performance-based equity awards that vest upon achievement of certain performance milestones. The fair value of RSUs is equal to the fair value of the Company’s common stock on the date of grant. The Company’s RSUs activity for the three months ended March 31, 2023 was as follows: Shares Weighted Average Outstanding as of December 31, 2022 25,594,035 $ 12.66 Granted 9,124,995 7.81 Forfeited (664,787) 13.15 Vested (3,868,826) 12.60 Outstanding as of March 31, 2023 30,185,417 11.19 Fixed Value Equity Awards The Company issues fixed value equity awards to certain employees as a part of their compensation package. These awards are issued as RSUs out of the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan) and are accounted for as liability classified awards under ASC 718 — Stock Compensation. Fixed value equity awards granted have service-based conditions only and vest quarterly over a period of up to four years. These awards represent a fixed dollar amount settled in a variable number of shares determined at each vesting period. Stock-based compensation expense related to these awards was $2.9 million and $1.8 million for the three months ended March 31, 2023 and 2022, respectively. Optogration Milestone Awards As part of the acquisition of Optogration, Inc. in August 2021, the Company owed up to $22.0 million of post combination compensation related to certain service and performance conditions (“Optogration Milestone Awards”). In August 2022, the Company issued 1,632,056 shares of Class A common stock for $11.0 million of the Optogration Milestone Awards due to achievement of the service and performance conditions. As of March 31, 2023, it is probable that the service and performance conditions for the remaining $11.0 million obligation will be met. Freedom Photonics Awards As part of the acquisition of Freedom Photonics LLC (“Freedom Photonics”) in April 2022, the Company owes up to $28.3 million of post combination compensation related to certain service and performance conditions. As of March 31, 2023, it is probable that the remaining conditions will be met. Solfice Awards The Company owes up to $0.7 million of compensation related to certain service and performance conditions related to the acquisition of certain assets from Solfice Research, Inc. in June 2022. As of March 31, 2023, it is probable that the conditions will be met. Management Awards On May 2, 2022, the Board granted an award of 10.8 million RSUs to Austin Russell, the Company’s Chief Executive Officer. The grant date fair value per share of the award granted to Mr. Russell was $8.70 per share. On August 19, 2022, the Board granted 500,000 RSUs to each of Thomas Fennimore, the Company’s Chief Financial Officer, and Alan Prescott, the Company’s Chief Legal Officer. The grant date fair value per share of the awards granted to Mr. Fennimore and Mr. Prescott was $6.12 per share. These awards to Mr. Russell, Mr. Fennimore and Mr. Prescott are subject to all of the following vesting conditions: • Public Market condition: Achievement of three stock price milestones: $50 or more, $60 or more, and $70 or more. The stock price will be measured based on the volume-weighted average price per share for 90 consecutive trading days; • Service condition: Approximately 7-years of vesting; and • Performance condition: Start of production for at least one series production program. On March 16, 2023, the Board granted a $12.0 million stock-price based award to the Company’s Executive Vice President & General Manager that vests in six tranches of $2.0 million, upon achievement of the six stock price milestones of $20, $25, $30, $40, $50 and $60 based on 90 trading day volume-weighted average price of a share of common stock over a 7.0 years performance period. The grant date fair value per share of the award granted to the said executive was $8.58 per share. The Company measured the compensation cost for the above management awards using a Monte Carlo simulation model and recorded $5.7 million in stock-based compensation expense related to these awards in the three months ended March 31, 2023. Compensation expense Stock-based compensation expense by function was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of sales $ 2,662 $ 1,786 Research and development 17,471 7,102 Sales and marketing 5,828 2,868 General and administrative 29,993 14,942 Total $ 55,954 $ 26,698 Stock-based compensation expense by type of award was as follows (in thousands): Three Months Ended March 31, 2023 2022 Equity Classified Awards: Stock options $ 727 $ 522 RSAs 60 (166) RSUs 38,332 21,509 Management awards 5,659 — ESPP 403 — Liability Classified Awards: Equity settled fixed value 2,881 1,780 Optogration 2,581 3,053 Freedom Photonics 4,555 — Other 756 — Total $ 55,954 $ 26,698

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Provision for income taxes for the three months ended March 31, 2023 and 2022 was $— million and $0.4 million, respectively. The effective tax rate was 0.0% and 0.5% for the three months ended March 31, 2023 and 2022, respectively . The effective tax rates differ significantly from the statutory tax rate of 21%, primarily due to the Company’s valuation allowance movement in each period presented.

Leases

Leases	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Leases	Leases The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through November 2028. In March 2023, the Company entered into a lease agreement commencing on November 1, 2023 for a term of 61 months through November 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one The components of lease expenses were as follows (in thousands): Three Months Ended March 31, 2023 2022 Operating lease cost $ 1,972 $ 1,116 Variable lease cost 516 385 Total operating lease cost $ 2,488 $ 1,501 Supplemental cash flow information related to leases was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (1,695) $ (1,314) Right of use assets obtained in exchange for lease obligations: Operating leases 1,211 5,746 Supplemental balance sheet information related to leases was as follows (in thousands): March 31, 2023 December 31, 2022 Operating leases: Operating lease right-of-use assets $ 20,986 $ 21,244 Operating lease liabilities: Operating lease liabilities, current $ 5,906 $ 5,953 Operating lease liabilities, non-current 17,061 16,989 Total operating lease liabilities $ 22,967 $ 22,942 Weighted average remaining terms were as follows (in years): March 31, 2023 December 31, 2022 Weighted average remaining lease term Operating leases 4.38 4.43 Weighted average discount rates were as follows: March 31, 2023 December 31, 2022 Weighted average discount rate Operating leases 5.65 % 5.45 % Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2023 (remaining nine months) $ 4,759 2024 5,400 2025 5,477 2026 5,016 2027 4,208 2028 1,363 Total lease payments 26,223 Less: imputed interest (3,256) Total leases liabilities $ 22,967
Leases	Leases The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through November 2028. In March 2023, the Company entered into a lease agreement commencing on November 1, 2023 for a term of 61 months through November 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one The components of lease expenses were as follows (in thousands): Three Months Ended March 31, 2023 2022 Operating lease cost $ 1,972 $ 1,116 Variable lease cost 516 385 Total operating lease cost $ 2,488 $ 1,501 Supplemental cash flow information related to leases was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (1,695) $ (1,314) Right of use assets obtained in exchange for lease obligations: Operating leases 1,211 5,746 Supplemental balance sheet information related to leases was as follows (in thousands): March 31, 2023 December 31, 2022 Operating leases: Operating lease right-of-use assets $ 20,986 $ 21,244 Operating lease liabilities: Operating lease liabilities, current $ 5,906 $ 5,953 Operating lease liabilities, non-current 17,061 16,989 Total operating lease liabilities $ 22,967 $ 22,942 Weighted average remaining terms were as follows (in years): March 31, 2023 December 31, 2022 Weighted average remaining lease term Operating leases 4.38 4.43 Weighted average discount rates were as follows: March 31, 2023 December 31, 2022 Weighted average discount rate Operating leases 5.65 % 5.45 % Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2023 (remaining nine months) $ 4,759 2024 5,400 2025 5,477 2026 5,016 2027 4,208 2028 1,363 Total lease payments 26,223 Less: imputed interest (3,256) Total leases liabilities $ 22,967

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase and Other Obligations The Company purchases goods and services from a variety of suppliers in the ordinary course of business. Purchase obligations are defined as agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum, or variable price provisions, and the approximate timing of the transaction. The Company had purchase obligations primarily for purchases of inventory, R&D, and general and administrative activities totaling $81.3 million as of March 31, 2023. Legal Matters From time to time, the Company is involved in actions, claims, suits and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates. The Company’s current legal accrual is not material to the financial statements.

Segment and Customer Concentrat

Segment and Customer Concentration Information	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Segment and Customer Concentration Information	Segment and Customer Concentration Information Reportable segments are (i) Autonomy Solutions and (ii) ATS. These segments reflect the way the chief operating decision maker (“CODM”) evaluates the Company’s business performance and manages its operations. Each segment has distinct product offerings, customers and market penetration. The Chief Executive Officer is the CODM of the Company. Autonomy Solutions This segment manufactures and distributes commercial lidar sensors that measure distance using laser light for automotive mobility applications. This segment is impacted by trends in the autonomous vehicles and associated infrastructure/technology sector. ATS This segment is in the business of development of semiconductor technology based lasers and sensors. This segment also designs, tests and provides consulting services for development of integrated circuits. This segment is impacted by trends in and the strength of the automobile and aeronautics sector as well as government spending in military and defense activities. The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands): Three Months Ended March 31, 2023 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 10,673 $ 3,836 $ 14,509 $ — $ 14,509 Revenues from internal customer 4,555 4,550 9,105 (9,105) — Total revenue $ 15,228 $ 8,386 $ 23,614 $ (9,105) $ 14,509 Depreciation and amortization $ 2,326 $ 661 $ 2,987 $ — $ 2,987 Operating income (loss) (141,584) (596) (142,180) 285 (141,895) Other significant items: Segment assets 735,264 64,157 799,421 (141,070) 658,351 Inventories, net 14,477 479 14,956 (38) 14,918 Three Months Ended March 31, 2022 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 5,898 $ 957 $ 6,855 $ — $ 6,855 Revenues from internal customer 2,361 2,156 4,517 (4,517) — Total revenue $ 8,259 $ 3,113 $ 11,372 $ (4,517) $ 6,855 Depreciation and amortization $ 544 $ 261 $ 805 $ — $ 805 Operating income (loss) (82,177) 270 (81,907) (424) (82,331) Other significant items: Segment assets 815,160 10,992 826,152 (18,352) 807,800 Inventories, net 9,813 199 10,012 — 10,012 (1) Represents the eliminations of all intercompany balances and transactions during the period presented. Two customers accounted for 28% and 24% of the Company’s revenue for the three months ended March 31, 2023. Two customers accounted for 52% and 23% of the Company’s revenue for the three months ended March 31, 2022.

Subsequent Event

Subsequent Event	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Event	Subsequent EventOn May 8, 2023, the Company entered into an agreement to issue 1,652,892 shares of Class A common stock to a wholly-owned subsidiary of TPK Universal Solutions Limited, for a cash purchase price of $10 million pursuant to a private placement in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended. Additionally, the Company granted an option to purchase 1,652,892 additional shares of Class A common stock worth $10 million within 90 days following the date of the agreement.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Annual Report”) filed with the SEC on February 28, 2023. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory reserves, valuation allowance for deferred tax assets, valuation of warrants issued in a private placement in connection with the initial public offering of Gores Metropoulos, Inc. (the Company’s former name) (“Private Warrants”), valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.
Segment Information	Segment Information The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments: (i) “Autonomy Solutions,” which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In January 2023, the Company acquired certain assets from Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd. (individually and collectively, “Seagate”). Assets purchased from Seagate have been included in the Autonomy Solutions segment. (ii) “Advanced Technologies and Services” (“ATS”), which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits.
Concentration of Credit Risk	Concentration of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s deposits exceed federally insured limits. Cash held by foreign subsidiaries of the Company as of March 31, 2023 and December 31, 2022 was not material.
Recently Accounting Pronouncements Not Yet Effective	Recent Accounting Pronouncements Not Yet Effective The Company has reviewed, or is in the process of evaluating, all issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such accounting pronouncements will cause a material impact on its consolidated financial position, operating results or statements of cash flows.
Fair Value Measurements	Fair Value Measurements As of March 31, 2023, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques.

Business Combinations and Acq_2

Business Combinations and Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Purchase Price Allocation To Assets Acquired	The following table summarizes the preliminary purchase price allocation to assets acquired (in thousands): Preliminary Recorded Value Property plant and equipment $ 3,163 Developed Technology (1) 8,240 Goodwill (2) 1,063 Other assets 142 Net assets acquired $ 12,608 (1) Technology and IP Licenses were measured using the cost approach. Significant inputs used as part of the valuation of intangible assets include personnel costs, overhead costs, developer’s profit, and expected time to reproduce. (2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included workforce and expected synergies derived from the technology application to the Company’s current technological platforms. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the Autonomy Solutions segment, which is also deemed the reporting unit.
Schedule of Finite-Lived Intangible Assets Acquired as Part of Asset Acquisition	Identifiable intangible assets recognized (in thousands): Useful Life Preliminary Recorded Value Developed technology 4 — 6 years $ 8,240

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands): Three Months Ended March 31, 2023 2022 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 13,198 91 % $ 4,968 73 % Asia Pacific 592 4 % 1,860 27 % Europe and Middle East 719 5 % 27 — % Total $ 14,509 100 % $ 6,855 100 % Revenue by timing of recognition: Recognized at a point in time $ 7,358 51 % $ 1,541 22 % Recognized over time 7,151 49 % 5,314 78 % Total $ 14,509 100 % $ 6,855 100 % Revenue by segment: Autonomy Solutions $ 10,673 74 % $ 5,898 86 % ATS 3,836 26 % 957 14 % Total $ 14,509 100 % $ 6,855 100 %
Schedule of Opening and Closing Balances of Contract Liabilities and Significant Changes in Contract Liabilities	The opening and closing balances of contract assets were as follows (in thousands): March 31, 2023 December 31, 2022 Contract assets, current $ 7,904 $ 15,395 Contract assets, non-current 5,985 2,575 Ending balance $ 13,889 $ 17,970 The significant changes in contract assets balances consisted of the following (in thousands): March 31, 2023 December 31, 2022 Beginning balance $ 17,970 $ 9,907 Amounts billed that were included in the contract assets beginning balance (8,414) (4,228) Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 4,333 12,291 Ending balance $ 13,889 $ 17,970 The opening and closing balances of contract liabilities were as follows (in thousands): March 31, 2023 December 31, 2022 Contract liabilities, current $ 4,558 $ 1,993 Contract liabilities, non-current 414 1,015 Ending balance $ 4,972 $ 3,008 The significant changes in contract liabilities balances consisted of the following (in thousands): March 31, 2023 December 31, 2022 Beginning balance $ 3,008 $ 898 Revenue recognized that was included in the contract liabilities beginning balance (1,492) (489) Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 3,456 2,599 Ending balance $ 4,972 $ 3,008

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Debt Securities, Available-for-sale	The Company’s investments in debt securities consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Cost Gross Gross Fair Value U.S. treasury securities $ 228,254 $ 27 $ (1,392) $ 226,889 U.S. agency and government sponsored securities 5,000 — (25) 4,975 Commercial paper 27,286 — (84) 27,202 Corporate bonds 73,411 — (493) 72,918 Asset-backed securities 4,523 — (33) 4,490 Total debt securities $ 338,474 $ 27 $ (2,027) $ 336,474 Included in cash and cash equivalents $ 29,828 $ 2 $ (3) $ 29,827 Included in marketable securities 308,646 25 (2,024) 306,647 December 31, 2022 Cost Gross Gross Fair Value U.S. treasury securities $ 191,075 $ 3 $ (2,598) $ 188,480 U.S. agency and government sponsored securities 4,999 — (75) 4,924 Commercial paper 74,755 — (232) 74,523 Corporate bonds 111,123 — (1,214) 109,909 Asset-backed securities 11,945 — (110) 11,835 Total debt securities $ 393,897 $ 3 $ (4,229) $ 389,671 Included in marketable securities $ 393,897 $ 3 $ (4,229) $ 389,671
Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments	The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 December 31, 2022 Gross Fair Value Gross Fair Value U.S. treasury securities $ (1,392) $ 174,013 $ (2,598) $ 158,888 U.S. agency and government sponsored securities (25) 4,975 (75) 4,924 Commercial paper (84) 27,202 (232) 74,523 Corporate bonds (493) 72,918 (1,214) 109,909 Asset-backed securities (33) 4,490 (110) 11,835 Total $ (2,027) $ 283,598 $ (4,229) $ 360,079
Schedule of Equity Investments Included in Marketable Securities	The Company’s equity investments consisted of the following as of March 31, 2023 and December 31, 2022 (in thousands): Condensed Consolidated Balance Sheets Location March 31, 2023 December 31, 2022 Money market funds (1) Cash and cash equivalents $ 34,202 $ 42,056 Marketable equity investments (1) Marketable securities 25,716 29,643 Non-marketable equity investment measured using the measurement alternative (2) Other non-current assets 4,000 4,000 Total $ 63,918 $ 75,699 (1) Investments with readily determinable fair values. (2) Investment in privately held company without readily determinable fair value.

Financial Statement Components

Financial Statement Components (Tables)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	Cash and cash equivalents consisted of the following (in thousands): March 31, 2023 December 31, 2022 Cash $ 25,904 $ 27,496 Money market funds 34,202 42,056 U.S. treasury securities 29,827 — Total cash and cash equivalents $ 89,933 $ 69,552
Schedule of Inventories, net	Inventory comprised of the following (in thousands): March 31, 2023 December 31, 2022 Raw materials $ 8,066 $ 3,614 Work-in-process 3,706 2,329 Finished goods 3,146 2,849 Total inventories, net $ 14,918 $ 8,792
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Prepaid expenses $ 14,729 $ 15,653 Contract assets 7,904 15,395 Advance payments to vendors 5,394 7,919 Other receivables 5,832 5,236 Total prepaid expenses and other current assets $ 33,859 $ 44,203
Schedule of Property and Equipment	Property and equipment consisted of the following (in thousands): March 31, 2023 December 31, 2022 Machinery and equipment $ 25,817 $ 14,047 Computer hardware and software 7,978 6,797 Land 1,001 1,001 Leasehold improvements 19,359 885 Vehicles, including demonstration fleet 3,357 3,222 Furniture and fixtures 817 818 Construction in progress 32,143 13,642 Total property and equipment 90,472 40,412 Accumulated depreciation and amortization (12,077) (10,152) Total property and equipment, net $ 78,395 $ 30,260
Schedule of Finite-Lived Intangible Assets	The following table summarizes the activity in the Company’s intangible assets (in thousands): March 31, 2023 December 31, 2022 Beginning of the period $ 22,077 $ 2,424 Additions 8,240 21,890 Amortization (1,062) (2,237) End of the period $ 29,255 $ 22,077 The components of intangible assets were as follows (in thousands): March 31, 2023 December 31, 2022 Gross Accumulated Net Weighted Average Gross Accumulated Net Weighted Customer relationships $ 3,730 $ (867) $ 2,863 4.2 $ 3,730 $ (664) $ 3,066 4.4 Customer backlog 650 (390) 260 0.7 650 (292) 358 0.9 Tradename 620 (245) 375 3.0 620 (214) 406 3.3 Assembled workforce 130 (130) — — 130 (130) — — Developed technology 20,150 (1,893) 18,257 6.3 11,910 (1,163) 10,747 7.5 IPR&D 7,500 — 7,500 — 7,500 — 7,500 — Total intangible assets $ 32,780 $ (3,525) $ 29,255 5.9 $ 24,540 $ (2,463) $ 22,077 6.6
Schedule of Future Amortization Expense	As of March 31, 2023, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future 2023 (remaining nine months) $ 3,261 2024 4,001 2025 4,001 2026 3,354 2027 3,138 Thereafter 4,000 IPR&D 7,500 Total $ 29,255
Schedule of Goodwill	The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands): Autonomy Solutions ATS Total Balance as of December 31, 2022 $ 687 $ 18,129 $ 18,816 Goodwill related to acquisition of Seagate’s lidar business (see Note 3) 1,063 — 1,063 Balance as of March 31, 2023 $ 1,750 $ 18,129 $ 19,879
Schedule of Other Noncurrent Assets	Other non-current assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Security deposits $ 5,078 $ 5,495 Non-marketable equity investment 4,000 4,000 Advance payment for capital projects — 27,683 Contract assets 5,985 2,575 Other non-current assets 423 591 Total other non-current assets $ 15,486 $ 40,344
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following (in thousands): March 31, 2023 December 31, 2022 Accrued compensation and benefits $ 21,639 $ 16,682 Accrued expenses 24,592 22,358 Warranty reserves 4,170 3,584 Contract liabilities 4,558 1,993 Accrued interest payable 2,286 359 Contract losses 6,890 7,526 Other 527 460 Total accrued and other current liabilities $ 64,662 $ 52,962

Convertible Senior Notes and _2

Convertible Senior Notes and Capped Call Transactions (Tables)	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Net Carrying Amount	The net carrying amount of the Convertible Senior Notes was as follows (in thousands): March 31, 2023 December 31, 2022 Principal $ 625,000 $ 625,000 Unamortized debt discount and issuance costs (11,999) (12,808) Net carrying amount $ 613,001 $ 612,192
Schedule of Interest Expense	The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands): Three Months Ended March 31, 2023 2022 Contractual interest expense $ 1,926 $ 1,926 Amortization of debt discount and issuance costs 809 809 Total interest expense $ 2,735 $ 2,735

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Changes in Level 3 Liabilities Measured at Fair Value	The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands): Private Warrants Balance as of December 31, 2022 $ 3,005 Change in fair value of outstanding warrants 1,054 Balance as of March 31, 2023 $ 4,059
Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used	The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): Fair Value (in thousands) Measured as of March 31, 2023 Using: Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 34,202 $ — $ — $ 34,202 U.S. treasury securities 29,827 — — 29,827 Total cash equivalents $ 64,029 $ — $ — $ 64,029 Marketable investments: U.S. treasury securities $ 197,062 $ — $ — $ 197,062 U.S. agency and government sponsored securities — 4,975 — 4,975 Commercial paper — 27,202 — 27,202 Corporate bonds — 72,918 — 72,918 Asset-backed securities — 4,490 — 4,490 Marketable equity investments 25,716 — — 25,716 Total marketable investments $ 222,778 $ 109,585 $ — $ 332,363 Liabilities: Private Warrants $ — $ — $ 4,059 $ 4,059 Fair Value (in thousands) Measured as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 42,056 $ — $ — $ 42,056 Total cash equivalents $ 42,056 $ — $ — $ 42,056 Marketable investments: U.S. treasury securities $ 188,480 $ — $ — $ 188,480 U.S. agency and government sponsored securities — 4,924 — 4,924 Commercial paper — 74,523 — 74,523 Corporate bonds — 109,909 — 109,909 Asset-backed securities — 11,835 — 11,835 Marketable equity investments 29,643 — — 29,643 Total marketable investments $ 218,123 $ 201,191 $ — $ 419,314 Liabilities: Private Warrants $ — $ — $ 3,005 $ 3,005

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Loss Per Share	The following table sets forth the computation of basic and diluted loss per share for the three months ended March 31, 2023 and 2022 (in thousands, except for share and per share amounts): Three Months Ended March 31, 2023 2022 Numerator: Net loss $ (146,774) $ (88,333) Denominator: Weighted average common shares outstanding—Basic 370,742,917 348,683,836 Weighted average common shares outstanding—Diluted 370,742,917 348,683,836 Net loss per share attributable to common shareholders—Basic and Diluted $ (0.40) $ (0.25)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive or related contingencies on issuance of shares had not been met as of March 31, 2023: March 31, 2023 Warrants 5,757,549 Stock-based awards—Equity classified 36,303,214 Stock-based awards—Liability classified 11,365,535 Vendor stock-in-lieu of cash program 816,705 Convertible Senior Notes 31,279,716 Earn-out shares 8,606,717 Total 94,129,436

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Schedule of Vendor Stock-in-lieu of Cash Program	The Company’s vendor Stock-in-lieu of Cash Program activity for the three months ended March 31, 2023 was as follows: Shares Weighted Average Unvested shares as of December 31, 2022 1,047,151 $ 11.90 Granted 1,627,690 6.43 Vested (1,976,031) 7.02 Unvested shares as of March 31, 2023 698,810 12.96

Stock-based Compensation (Table

Stock-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	The Company’s stock option activity for the three months ended March 31, 2023 was as follows: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2022 8,162,850 $ 1.74 Exercised (622,042) 1.67 Cancelled/Forfeited (155,430) 1.67 Outstanding as of March 31, 2023 7,385,378 1.74 6.73 $ 35,694
Schedule of Restricted Stock Awards Activity	The Company’s RSAs activity for the three months ended March 31, 2023 was as follows: Shares Weighted Average Outstanding as of December 31, 2022 64,486 $ 1.29 Vested (52,826) 1.30 Outstanding as of March 31, 2023 11,660 1.29 The Company’s RSUs activity for the three months ended March 31, 2023 was as follows: Shares Weighted Average Outstanding as of December 31, 2022 25,594,035 $ 12.66 Granted 9,124,995 7.81 Forfeited (664,787) 13.15 Vested (3,868,826) 12.60 Outstanding as of March 31, 2023 30,185,417 11.19
Schedule of Stock-based Compensation Expense by Function	Stock-based compensation expense by function was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of sales $ 2,662 $ 1,786 Research and development 17,471 7,102 Sales and marketing 5,828 2,868 General and administrative 29,993 14,942 Total $ 55,954 $ 26,698 Stock-based compensation expense by type of award was as follows (in thousands): Three Months Ended March 31, 2023 2022 Equity Classified Awards: Stock options $ 727 $ 522 RSAs 60 (166) RSUs 38,332 21,509 Management awards 5,659 — ESPP 403 — Liability Classified Awards: Equity settled fixed value 2,881 1,780 Optogration 2,581 3,053 Freedom Photonics 4,555 — Other 756 — Total $ 55,954 $ 26,698

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Schedule of Components of Lease Expenses, Supplemental Cash Flow Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates	The components of lease expenses were as follows (in thousands): Three Months Ended March 31, 2023 2022 Operating lease cost $ 1,972 $ 1,116 Variable lease cost 516 385 Total operating lease cost $ 2,488 $ 1,501 Supplemental cash flow information related to leases was as follows (in thousands): Three Months Ended March 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (1,695) $ (1,314) Right of use assets obtained in exchange for lease obligations: Operating leases 1,211 5,746 Weighted average remaining terms were as follows (in years): March 31, 2023 December 31, 2022 Weighted average remaining lease term Operating leases 4.38 4.43 Weighted average discount rates were as follows: March 31, 2023 December 31, 2022 Weighted average discount rate Operating leases 5.65 % 5.45 %
Schedule of Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases was as follows (in thousands): March 31, 2023 December 31, 2022 Operating leases: Operating lease right-of-use assets $ 20,986 $ 21,244 Operating lease liabilities: Operating lease liabilities, current $ 5,906 $ 5,953 Operating lease liabilities, non-current 17,061 16,989 Total operating lease liabilities $ 22,967 $ 22,942
Schedule of Maturities of Lease Liabilities	Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2023 (remaining nine months) $ 4,759 2024 5,400 2025 5,477 2026 5,016 2027 4,208 2028 1,363 Total lease payments 26,223 Less: imputed interest (3,256) Total leases liabilities $ 22,967

Segment and Customer Concentr_2

Segment and Customer Concentration Information (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Schedule of Segment Operating Results and Reconciliations to the Consolidated Balances	The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands): Three Months Ended March 31, 2023 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 10,673 $ 3,836 $ 14,509 $ — $ 14,509 Revenues from internal customer 4,555 4,550 9,105 (9,105) — Total revenue $ 15,228 $ 8,386 $ 23,614 $ (9,105) $ 14,509 Depreciation and amortization $ 2,326 $ 661 $ 2,987 $ — $ 2,987 Operating income (loss) (141,584) (596) (142,180) 285 (141,895) Other significant items: Segment assets 735,264 64,157 799,421 (141,070) 658,351 Inventories, net 14,477 479 14,956 (38) 14,918 Three Months Ended March 31, 2022 Autonomy ATS Total Eliminations (1) Total Revenue: Revenues from external customers $ 5,898 $ 957 $ 6,855 $ — $ 6,855 Revenues from internal customer 2,361 2,156 4,517 (4,517) — Total revenue $ 8,259 $ 3,113 $ 11,372 $ (4,517) $ 6,855 Depreciation and amortization $ 544 $ 261 $ 805 $ — $ 805 Operating income (loss) (82,177) 270 (81,907) (424) (82,331) Other significant items: Segment assets 815,160 10,992 826,152 (18,352) 807,800 Inventories, net 9,813 199 10,012 — 10,012 (1) Represents the eliminations of all intercompany balances and transactions during the period presented.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details)	3 Months Ended
	Mar. 31, 2023 operating_segment
Accounting Policies [Abstract]
Number of operating segments	2

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) - Accounts Receivable - Customer Concentration Risk	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Customer One
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	33%	27%
Customer Two
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	23%	23%
Customer Three
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	17%	11%

Business Combinations and Acq_3

Business Combinations and Acquisitions - Narrative (Details) $ in Millions	Jan. 18, 2023 USD ($)
Seagate
Business Acquisition [Line Items]
Asset acquisition, consideration transferred	$ 12.6

Business Combinations and Acq_4

Business Combinations and Acquisitions - Schedule of Purchase Price Allocation (Details) - USD ($) $ in Thousands		3 Months Ended	12 Months Ended
	Jan. 18, 2023	Mar. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Finite-lived intangible assets acquired		$ 8,240	$ 21,890
Goodwill		1,063
Autonomy Solutions
Business Acquisition [Line Items]
Goodwill		$ 1,063
Seagate
Business Acquisition [Line Items]
Property plant and equipment	$ 3,163
Other assets	142
Net assets acquired	12,608
Seagate | Autonomy Solutions
Business Acquisition [Line Items]
Goodwill	1,063
Seagate | Developed technology
Business Acquisition [Line Items]
Finite-lived intangible assets acquired	$ 8,240

Business Combinations and Acq_5

Business Combinations and Acquisitions - Components of Intangible Assets and Estimated Useful Lives (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Jan. 18, 2023
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)	5 years 10 months 24 days	6 years 7 months 6 days
Developed technology
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)	6 years 3 months 18 days	7 years 6 months
Preliminary Recorded Value	$ 20,150	$ 11,910
Seagate | Developed technology
Business Acquisition [Line Items]
Preliminary Recorded Value			$ 8,240
Seagate | Developed technology | Minimum
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)	4 years
Seagate | Developed technology | Maximum
Business Acquisition [Line Items]
Weighted Average Remaining Period (Years)	6 years

Revenue - Schedule of Disaggreg

Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 14,509	$ 6,855
Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%
Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%
Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%
Autonomy Solutions
Disaggregation of Revenue [Line Items]
Revenue	$ 10,673	$ 5,898
Autonomy Solutions | Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	74%	86%
ATS
Disaggregation of Revenue [Line Items]
Revenue	$ 3,836	$ 957
ATS | Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	26%	14%
Recognized at a point in time
Disaggregation of Revenue [Line Items]
Revenue	$ 7,358	$ 1,541
Recognized at a point in time | Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	51%	22%
Recognized over time
Disaggregation of Revenue [Line Items]
Revenue	$ 7,151	$ 5,314
Recognized over time | Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	49%	78%
North America
Disaggregation of Revenue [Line Items]
Revenue	$ 13,198	$ 4,968
North America | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	91%	73%
Asia Pacific
Disaggregation of Revenue [Line Items]
Revenue	$ 592	$ 1,860
Asia Pacific | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	4%	27%
Europe and Middle East
Disaggregation of Revenue [Line Items]
Revenue	$ 719	$ 27
Europe and Middle East | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	5%	0%

Revenue - Narrative (Details)

Revenue - Narrative (Details)	Mar. 31, 2020 tranche
VCTF warrant
Class of Warrant or Right [Line Items]
Number of tranches	2

Revenue - Schedule of Opening a

Revenue - Schedule of Opening and Closing Balances of Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Contract With Customer Asset [Roll Forward]
Contract assets, current	$ 7,904	$ 15,395
Contract assets, non-current	5,985	2,575
Contract with customer, asset, total	13,889	17,970	$ 9,907
Contract with Customer, Liability [Roll Forward]
Contract liabilities, current	4,558	1,993
Contract liabilities, non-current	414	1,015
Contract with customer, liability, total	$ 4,972	$ 3,008	$ 898

Revenue - Schedule of Significa

Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2023	Jun. 30, 2022
Contract With Customer Asset [Roll Forward]
Beginning balance	$ 17,970	$ 9,907
Amounts billed that were included in the contract assets beginning balance	(8,414)	(4,228)
Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed	4,333	12,291
Ending balance	13,889
Contract with Customer, Liability [Roll Forward]
Beginning balance	3,008	898
Revenue recognized that was included in the contract liabilities beginning balance	(1,492)	(489)
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period	3,456	$ 2,599
Ending balance	$ 4,972

Revenue - Remaining Performance

Revenue - Remaining Performance Obligations (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 $ in Millions	Mar. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 37.7
Revenue, remaining performance obligation, percentage	83%
Revenue, remaining performance obligation, period	12 months

Investments - Schedule of Debt

Investments - Schedule of Debt Securities, Available-for-sale (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Cost	$ 338,474	$ 393,897
Gross Unrealized Gains	27	3
Gross Unrealized Losses	(2,027)	(4,229)
Fair Value	336,474	389,671
Included in cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Cost	29,828
Gross Unrealized Gains	2
Gross Unrealized Losses	(3)
Fair Value	29,827
Included in marketable securities
Debt Securities, Available-for-sale [Line Items]
Cost	308,646	393,897
Gross Unrealized Gains	25	3
Gross Unrealized Losses	(2,024)	(4,229)
Fair Value	306,647	389,671
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Cost	228,254	191,075
Gross Unrealized Gains	27	3
Gross Unrealized Losses	(1,392)	(2,598)
Fair Value	226,889	188,480
U.S. agency and government sponsored securities
Debt Securities, Available-for-sale [Line Items]
Cost	5,000	4,999
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(25)	(75)
Fair Value	4,975	4,924
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Cost	27,286	74,755
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(84)	(232)
Fair Value	27,202	74,523
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Cost	73,411	111,123
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(493)	(1,214)
Fair Value	72,918	109,909
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Cost	4,523	11,945
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(33)	(110)
Fair Value	$ 4,490	$ 11,835

Investments - Schedule of Gross

Investments - Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	$ (2,027)	$ (4,229)
Fair Value	283,598	360,079
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(1,392)	(2,598)
Fair Value	174,013	158,888
U.S. agency and government sponsored securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(25)	(75)
Fair Value	4,975	4,924
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(84)	(232)
Fair Value	27,202	74,523
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(493)	(1,214)
Fair Value	72,918	109,909
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(33)	(110)
Fair Value	$ 4,490	$ 11,835

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Available-for-sale securities in excess of fair value	$ 2,027,000	$ 4,229,000
Allowance for credit loss	$ 0

Investments - Schedule of Equit

Investments - Schedule of Equity Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	$ 63,918	$ 75,699
Money market funds | Cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	34,202	42,056
Marketable equity investments | Marketable securities
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	25,716	29,643
Non-marketable equity investment | Other non-current assets
Debt Securities, Available-for-sale [Line Items]
Non-marketable equity investment measured using the measurement alternative	$ 4,000	$ 4,000

Financial Statement Component_2

Financial Statement Components - Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 25,904	$ 27,496
Money market funds	34,202	42,056
U.S. treasury securities	29,827	0
Total cash and cash equivalents	$ 89,933	$ 69,552

Financial Statement Component_3

Financial Statement Components - Schedule of Inventories, net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 8,066		$ 3,614
Work-in-process	3,706		2,329
Finished goods	3,146		2,849
Total inventories, net	14,918	$ 10,012	$ 8,792
Inventory write-downs	$ 5,451	$ 1,356

Financial Statement Component_4

Financial Statement Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses	$ 14,729	$ 15,653
Contract assets	7,904	15,395
Advance payments to vendors	5,394	7,919
Other receivables	5,832	5,236
Total prepaid expenses and other current assets	$ 33,859	$ 44,203

Financial Statement Component_5

Financial Statement Components - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 90,472		$ 40,412
Accumulated depreciation and amortization	(12,077)		(10,152)
Total property and equipment, net	78,395		30,260
Depreciation and amortization	1,900	$ 700
Machinery and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	25,817		14,047
Computer hardware and software
Property, Plant and Equipment [Line Items]
Total property and equipment	7,978		6,797
Land
Property, Plant and Equipment [Line Items]
Total property and equipment	1,001		1,001
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	19,359		885
Vehicles, including demonstration fleet
Property, Plant and Equipment [Line Items]
Total property and equipment	3,357		3,222
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	817		818
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 32,143		$ 13,642

Financial Statement Component_6

Financial Statement Components - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Intangible Assets (Including Goodwill) [Roll Forward]
Beginning of the period	$ 22,077	$ 2,424	$ 2,424
Additions	8,240		21,890
Amortization	(1,062)	(100)	(2,237)
End of the period	29,255		22,077
Accumulated Amortization	$ (3,525)		$ (2,463)
Weighted Average Remaining Period (Years)	5 years 10 months 24 days		6 years 7 months 6 days
Amortization	$ 1,062	$ 100	$ 2,237
Indefinite-Lived Intangible Assets [Line Items]
IPR&D	7,500
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Gross Carrying Amount	32,780		24,540
Accumulated Amortization	(3,525)		(2,463)
Total	29,255		22,077
IPR&D
Indefinite-Lived Intangible Assets [Line Items]
IPR&D	7,500		7,500
Customer relationships
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	3,730		3,730
Accumulated Amortization	(867)		(664)
Net Carrying Amount	$ 2,863		$ 3,066
Weighted Average Remaining Period (Years)	4 years 2 months 12 days		4 years 4 months 24 days
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (867)		$ (664)
Customer backlog
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	650		650
Accumulated Amortization	(390)		(292)
Net Carrying Amount	$ 260		$ 358
Weighted Average Remaining Period (Years)	8 months 12 days		10 months 24 days
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (390)		$ (292)
Tradename
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	620		620
Accumulated Amortization	(245)		(214)
Net Carrying Amount	$ 375		$ 406
Weighted Average Remaining Period (Years)	3 years		3 years 3 months 18 days
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (245)		$ (214)
Assembled workforce
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	130		130
Accumulated Amortization	(130)		(130)
Net Carrying Amount	0		0
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(130)		(130)
Developed technology
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	20,150		11,910
Accumulated Amortization	(1,893)		(1,163)
Net Carrying Amount	$ 18,257		$ 10,747
Weighted Average Remaining Period (Years)	6 years 3 months 18 days		7 years 6 months
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (1,893)		$ (1,163)

Financial Statement Component_7

Financial Statement Components - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
2023 (remaining nine months)	$ 3,261
2024	4,001
2025	4,001
2026	3,354
2027	3,138
Thereafter	4,000
IPR&D	7,500
Total	$ 29,255	$ 22,077

Financial Statement Component_8

Financial Statement Components - Schedule of Goodwill (Details) - USD ($) $ in Thousands		3 Months Ended
	Jan. 18, 2023	Mar. 31, 2023
Goodwill [Roll Forward]
Balance as of December 31, 2022		$ 18,816
Goodwill related to acquisition of Seagate’s lidar business (see Note 3)		1,063
Balance as of March 31, 2023		19,879
Autonomy Solutions
Goodwill [Roll Forward]
Balance as of December 31, 2022		687
Goodwill related to acquisition of Seagate’s lidar business (see Note 3)		1,063
Balance as of March 31, 2023		1,750
Autonomy Solutions | Seagate
Goodwill [Roll Forward]
Goodwill related to acquisition of Seagate’s lidar business (see Note 3)	$ 1,063
ATS
Goodwill [Roll Forward]
Balance as of December 31, 2022		18,129
Balance as of March 31, 2023		18,129
ATS | Seagate
Goodwill [Roll Forward]
Goodwill related to acquisition of Seagate’s lidar business (see Note 3)		$ 0

Financial Statement Component_9

Financial Statement Components - Schedule of Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Security deposits	$ 5,078	$ 5,495
Non-marketable equity investment	4,000	4,000
Advance payment for capital projects	0	27,683
Contract assets	5,985	2,575
Other non-current assets	423	591
Other non-current assets	$ 15,486	$ 40,344

Financial Statement Componen_10

Financial Statement Components - Schedule of Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation and benefits	$ 21,639	$ 16,682
Accrued expenses	24,592	22,358
Warranty reserves	4,170	3,584
Contract liabilities	4,558	1,993
Accrued interest payable	2,286	359
Contract losses	6,890	7,526
Other	527	460
Total accrued and other current liabilities	64,662	$ 52,962
Estimated contract losses	$ 3,300		$ 400

Convertible Senior Notes and _3

Convertible Senior Notes and Capped Call Transactions - Narrative (Details)	1 Months Ended						3 Months Ended
	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) trading_day $ / shares	Dec. 31, 2021 USD ($) consecutive_trading_day $ / shares	Dec. 31, 2021 USD ($) consecutive_business_day $ / shares	Mar. 31, 2023 USD ($) $ / shares	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Accrued interest repaid							$ 1,900,000	$ 1,900,000
Stock option, capped calls, initial strike price (in dollars per share) | $ / shares	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98
Stock option, capped calls, initial cap price (in dollars per share) | $ / shares	$ 30.16	$ 30.16	$ 30.16	$ 30.16	$ 30.16	$ 30.16
Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares							$ 0.0001
Convertible Senior Notes Due 2026 | Convertible Debt
Debt Instrument [Line Items]
Principal	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000		$ 625,000,000
Interest rate (as a percent)	1.25%	1.25%	1.25%	1.25%	1.25%	1.25%
Proceeds from the issuance of debt	$ 75,000,000
Proceeds from convertible debt	$ 609,400,000
Debt instrument, convertible, shares issuable (in shares) | shares			50.0475
Conversion price (in dollars per share) | $ / shares	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98
Debt issuance costs, net	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000
Note term (in months)							3 years 8 months 15 days
Payments to purchase capped calls							$ 73,400,000
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days | trading_day				20
Debt instrument, convertible, threshold consecutive trading days | consecutive_trading_day					30
Debt instrument, redemption price, percentage		100%
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Debt instrument, convertible, threshold percentage of stock price trigger		130%
Debt instrument, convertible, threshold trading days | trading_day				20
Debt instrument, convertible, threshold consecutive trading days | consecutive_trading_day					30
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days					10	5
Debt instrument, convertible, threshold percent of conversion price triggering convertible feature		98%
Convertible Senior Notes Due 2026 | Convertible Debt | Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Convertible Senior Notes Due 2026 | Convertible Debt | Class A Common Stock | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, convertible, threshold percentage of stock price trigger		130%

Convertible Senior Notes and _4

Convertible Senior Notes and Capped Call Transactions - Schedule of Net Carrying Amount (Details) - Convertible Senior Notes Due 2026 - Convertible Debt - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Principal	$ 625,000,000	$ 625,000,000	$ 625,000,000
Unamortized debt discount and issuance costs	(11,999,000)	(12,808,000)
Net carrying amount	$ 613,001,000	$ 612,192,000

Convertible Senior Notes and _5

Convertible Senior Notes and Capped Call Transactions - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Debt Instrument [Line Items]
Total interest expense	$ 1,665	$ 3,280
Convertible Senior Notes Due 2026 | Convertible Debt
Debt Instrument [Line Items]
Contractual interest expense	1,926	1,926
Amortization of debt discount and issuance costs	809	809
Total interest expense	$ 2,735	$ 2,735

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) $ in Millions	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Level 3 | Expected Term | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants term (in years)	2 years 8 months 4 days
Level 3 | Price Volatility | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input (percent)	0.811
Level 3 | Risk-Free Interest Rate | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input (percent)	0.0389
Level 2
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible senior notes, fair value	$ 416.9	$ 352.5

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details) - Warrants - Private Warrants $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ 3,005
Change in fair value of outstanding warrants	1,054
Balance at end of period	$ 4,059

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets:
Marketable investments:	$ 336,474	$ 389,671
Liabilities:
Warrant liabilities	4,059	3,005
U.S. treasury securities
Assets:
Marketable investments:	226,889	188,480
U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,975	4,924
Corporate bonds
Assets:
Marketable investments:	72,918	109,909
Asset-backed securities
Assets:
Marketable investments:	4,490	11,835
Fair Value, Recurring
Assets:
Total cash equivalents	64,029	42,056
Marketable equity investments	25,716	29,643
Total marketable investments	332,363	419,314
Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	4,059	3,005
Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	197,062	188,480
Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,975	4,924
Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	27,202	74,523
Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	72,918	109,909
Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	4,490	11,835
Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	34,202	42,056
Fair Value, Recurring | U.S. treasury securities
Assets:
Total cash equivalents	29,827
Level 1 | Fair Value, Recurring
Assets:
Total cash equivalents	64,029	42,056
Marketable equity investments	25,716	29,643
Total marketable investments	222,778	218,123
Level 1 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	0	0
Level 1 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	197,062	188,480
Level 1 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	34,202	42,056
Level 1 | Fair Value, Recurring | U.S. treasury securities
Assets:
Total cash equivalents	29,827
Level 2 | Fair Value, Recurring
Assets:
Total cash equivalents	0	0
Marketable equity investments	0	0
Total marketable investments	109,585	201,191
Level 2 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	0	0
Level 2 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	0	0
Level 2 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,975	4,924
Level 2 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	27,202	74,523
Level 2 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	72,918	109,909
Level 2 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	4,490	11,835
Level 2 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	0	0
Level 2 | Fair Value, Recurring | U.S. treasury securities
Assets:
Total cash equivalents	0
Level 3 | Fair Value, Recurring
Assets:
Total cash equivalents	0	0
Marketable equity investments	0	0
Total marketable investments	0	0
Level 3 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	4,059	3,005
Level 3 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	0	$ 0
Level 3 | Fair Value, Recurring | U.S. treasury securities
Assets:
Total cash equivalents	$ 0

Earnings (Loss) Per Share - Sch

Earnings (Loss) Per Share - Schedule of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net loss	$ (146,774)	$ (88,333)
Denominator:
Weighted average common shares outstanding- Basic (in shares)	370,742,917	348,683,836
Weighted average common shares outstanding- Diluted (in shares)	370,742,917	348,683,836
Net loss per share attributable to common shareholders- Basic (in dollars per share)	$ (0.40)	$ (0.25)
Net loss per share attributable to common shareholders- Diluted (in dollars per share)	$ (0.40)	$ (0.25)

Earnings (Loss) Per Share - S_2

Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)	3 Months Ended
	Mar. 31, 2023 shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	94,129,436
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	5,757,549
Stock-based awards—Equity classified
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	36,303,214
Stock-based awards—Liability classified
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	11,365,535
Vendor stock-in-lieu of cash program
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	816,705
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	31,279,716
Earn-out shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	8,606,717

Earnings (Loss) Per Share - Nar

Earnings (Loss) Per Share - Narrative (Details)	Mar. 31, 2023 $ / shares
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion price (in dollars per share)	$ 19.981

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) $ / shares in Units, $ in Thousands		3 Months Ended
	Feb. 28, 2023 USD ($)	Mar. 31, 2023 USD ($) vote $ / shares shares	Mar. 31, 2022 USD ($)	Dec. 31, 2022 shares
Class of Stock [Line Items]
Sale of stock, gross proceeds | $		$ 1,039	$ 1,085
Vendor payments in shares in lieu of cash (in shares)		1,627,690
Vendor payments in stock in lieu of cash, liability | $		$ 11,600
Pony. AI, Inc
Class of Stock [Line Items]
Vendor payments in shares in lieu of cash (in shares)		1,564,822
Private Warrants
Class of Stock [Line Items]
Warrants outstanding (in shares)				1,668,269
Warrants exercised (in shares)		0
Share per warrant (in shares)		1
Stock price of warrants (in dollars per share) | $ / shares		$ 11.50
Equity Financing Program
Class of Stock [Line Items]
Stock issuance sales agreement, authorized offering amount | $	$ 75,000
Sale of stock, gross proceeds | $		$ 22,665
Class A Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		715,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001
Common stock, shares issued (in shares)		301,045,203
Common stock, shares outstanding (in shares)		279,181,753
Common stock, votes per share | vote		1
Class A Common Stock | Equity Financing Program
Class of Stock [Line Items]
Sale of stock (in shares)		2,759,689
Sale of stock, gross proceeds | $		$ 22,700
Common stock available for future issuance | $		$ 52,100
Class B Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		121,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001
Common stock, shares issued (in shares)		97,088,670
Common stock, shares outstanding (in shares)		97,088,670
Common stock, votes per share | vote		10

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Vendor Stock-in-lieu of Cash Program (Details) - Vendor stock-in-lieu of cash program	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Shares
Outstanding at beginning of period (in shares) | shares	1,047,151
Granted (in shares) | shares	1,627,690
Vested (in shares) | shares	(1,976,031)
Outstanding at end of period (in shares) | shares	698,810
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 11.90
Granted (in dollars per share) | $ / shares	6.43
Vested (in dollars per share) | $ / shares	7.02
Outstanding at end of period (in dollars per share) | $ / shares	$ 12.96

Stock-based Compensation - Narr

Stock-based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

6 Months Ended

45 Months Ended

Mar. 16, 2023 USD ($) trading_day $ / shares

Jan. 01, 2023 shares

Aug. 19, 2022 $ / shares shares

May 02, 2022 $ / shares shares

Aug. 31, 2022 USD ($) shares

Jun. 30, 2022 USD ($) shares

Apr. 30, 2022 USD ($)

Aug. 31, 2021 USD ($)

Mar. 31, 2023 USD ($) trading_day $ / shares shares

Mar. 31, 2022 USD ($)

Jun. 30, 2019

Mar. 31, 2023 USD ($) shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares issued upon vesting of each RSU

1

1

Intrinsic value of stock options exercised | $

$ 3,800

Fair value of options vested | $

1,100

Stock-based compensation expense | $

55,954

$ 26,698

Optogration Milestone Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Contingent stock consideration | $

$ 22,000

Freedom Photonics Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Contingent stock consideration | $

$ 28,300

Solfice

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Contingent stock consideration | $

$ 700

Class A Common Stock | Optogration Milestone Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Optogration milestone awards (in shares) | shares

1,632,056

Optogration milestone awards | $

$ 11,000

Optogration milestone awards, remaining obligations | $

11,000

$ 11,000

Stock-based awards—Liability classified | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Granted (in shares) | shares

0

Stock-based awards—Liability classified | Tranche One | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

Stock-based awards—Liability classified | Tranche Two | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

36 months

Award vesting percentage

75%

RSUs | Chief Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

10,800,000

Grant date fair value (in dollars per share)

$ 8.70

RSUs | Chief Legal officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

500,000

Grant date fair value (in dollars per share)

$ 6.12

RSUs | Chief Financial Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

500,000

Grant date fair value (in dollars per share)

$ 6.12

RSUs | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-based compensation expense | $

$ 5,700

Grant date fair value (in dollars per share)

$ 8.58

Consecutive trading days | trading_day

90

Service period (in years)

7 years

7 years

Granted | $

$ 12,000

Fair value of restricted stock vested | $

$ 2,000

Trading Days | trading_day

90

RSUs | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

6 years

RSUs | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

9,124,995

RSUs | Tranche One | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

$ 20

RSUs | Tranche Two | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

25

RSUs | Tranche Three | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

30

RSUs | Tranche Four | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

40

RSUs | Tranche Five | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

50

RSUs | Tranche Six | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

$ 60

RSUs | Achievement of stock price one | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

$ 50

RSUs | Achievement of stock price two | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

60

RSUs | Achievement of stock price three | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share)

$ 70

2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares authorized for issuance (in shares) | shares

36,588,278

36,588,278

2020 Plan | Equity settled fixed value | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Stock-based compensation expense | $

$ 2,900

$ 1,800

Amended 2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Additional shares authorized for issuance (in shares) | shares

36,000,000

Percentage of outstanding stock maximum

5%

Incremental number of shares authorized (in shares) | shares

40,000,000

Amended 2020 Plan | Class A Common Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Additional shares authorized for issuance (in shares) | shares

18,358,365

2015 Plan | Stock-based awards—Equity classified

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Award expiration period (in years)

10 years

2015 Plan | Stock-based awards—Equity classified | Tranche One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

2015 Plan | Stock-based awards—Equity classified | Tranche Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

36 months

Award vesting percentage

75%

Stock-based Compensation - Sche

Stock-based Compensation - Schedule of Stock Option Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares
Number of Common Stock Options
Outstanding at beginning of period (in shares) | shares	8,162,850
Exercised (in shares) | shares	(622,042)
Cancelled/Forfeited (in shares) | shares	(155,430)
Outstanding at end of period (in shares) | shares	7,385,378
Weighted- Average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 1.74
Exercised (in dollars per share) | $ / shares	1.67
Cancelled/Forfeited (in dollars per share) | $ / shares	1.67
Outstanding at end of period (in dollars per share) | $ / shares	$ 1.74
Weighted- Average Remaining Contractual Life (Years)
Outstanding balance	6 years 8 months 23 days
Aggregate Intrinsic Value (In Thousands)
Outstanding balance | $	$ 35,694

Stock-based Compensation - Sc_2

Stock-based Compensation - Schedule of Restricted Stock Awards Activity (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Stock-based awards—Liability classified
Shares
Outstanding at beginning of period (in shares) | shares	64,486
Vested (in shares) | shares	(52,826)
Outstanding at end of period (in shares) | shares	11,660
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share)	$ 1.29
Vested (in dollars per share)	1.30
Outstanding at end of period (in dollars per share)	$ 1.29
RSUs
Shares
Outstanding at beginning of period (in shares) | shares	25,594,035
Forfeited (in shares) | shares	(664,787)
Vested (in shares) | shares	(3,868,826)
Outstanding at end of period (in shares) | shares	30,185,417
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share)	$ 12.66
Granted (in dollars per share)	7.81
Forfeited (in dollars per share)	13.15
Vested (in dollars per share)	12.60
Outstanding at end of period (in dollars per share)	$ 11.19

Stock-based Compensation - Sc_3

Stock-based Compensation - Schedule of Stock-based Compensation Expense by Function (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 55,954	$ 26,698
Equity settled fixed value
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	2,881	1,780
Optogration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	2,581	3,053
Freedom Photonics
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	4,555	0
Other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	756	0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	727	522
RSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	60	(166)
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	38,332	21,509
Management awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	5,659	0
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	403	0
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	2,662	1,786
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	17,471	7,102
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	5,828	2,868
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 29,993	$ 14,942

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 0	$ 404
Effective tax rate, percent	0%	0.50%

Leases - Narrative (Details)

Leases - Narrative (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) renewal_option
Lessee, Lease, Description [Line Items]
Term of lease (in moths)	61 months
Short-term leases	$ 0
Sublease income	$ 0
Minimum
Lessee, Lease, Description [Line Items]
Number of renewal options | renewal_option	1
Renewal lease term (in years)	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal lease term (in years)	6 years

Leases - Schedule of Components

Leases - Schedule of Components of Lease Expenses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating lease cost	$ 1,972	$ 1,116
Variable lease cost	516	385
Total operating lease cost	$ 2,488	$ 1,501

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases included in operating activities	$ (1,695)	$ (1,314)
Right of use assets obtained in exchange for lease obligations:
Operating leases	$ 1,211	$ 5,746

Leases - Schedule of Suppleme_2

Leases - Schedule of Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Operating leases:
Operating lease right-of-use assets	$ 20,986	$ 21,244
Operating lease liabilities, current	5,906	5,953
Operating lease liabilities, non-current	17,061	16,989
Total operating lease liabilities	$ 22,967	$ 22,942
Weighted average remaining lease term
Operating leases (in years)	4 years 4 months 17 days	4 years 5 months 4 days
Weighted average discount rate
Operating leases (as a percent)	5.65%	5.45%

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Operating Leases
2023 (remaining nine months)	$ 4,759
2024	5,400
2025	5,477
2026	5,016
2027	4,208
2028	1,363
Total lease payments	26,223
Less: imputed interest	(3,256)
Total leases liabilities	$ 22,967	$ 22,942

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	Mar. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation	$ 81.3

Segment and Customer Concentr_3

Segment and Customer Concentration Information - Schedule of Segment Operating Results and Reconciliation to the Consolidated Balances (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Revenue:
Revenue	$ 14,509	$ 6,855
Depreciation and amortization	2,987	805
Operating income (loss)	(141,895)	(82,331)
Other significant items:
Segment assets	658,351	807,800	$ 687,327
Inventories, net	14,918	10,012	$ 8,792
Reportable Segments
Revenue:
Revenue	23,614	11,372
Depreciation and amortization	2,987	805
Operating income (loss)	(142,180)	(81,907)
Other significant items:
Segment assets	799,421	826,152
Inventories, net	14,956	10,012
Eliminations
Revenue:
Revenue	(9,105)	(4,517)
Depreciation and amortization	0	0
Operating income (loss)	285	(424)
Other significant items:
Segment assets	(141,070)	(18,352)
Inventories, net	(38)	0
Autonomy Solutions
Revenue:
Revenue	10,673	5,898
Autonomy Solutions | Reportable Segments
Revenue:
Revenue	15,228	8,259
Depreciation and amortization	2,326	544
Operating income (loss)	(141,584)	(82,177)
Other significant items:
Segment assets	735,264	815,160
Inventories, net	14,477	9,813
Autonomy Solutions | Eliminations
Revenue:
Revenue	(4,555)	(2,361)
ATS
Revenue:
Revenue	3,836	957
ATS | Reportable Segments
Revenue:
Revenue	8,386	3,113
Depreciation and amortization	661	261
Operating income (loss)	(596)	270
Other significant items:
Segment assets	64,157	10,992
Inventories, net	479	199
ATS | Eliminations
Revenue:
Revenue	$ (4,550)	$ (2,156)

Segment and Customer Concentr_4

Segment and Customer Concentration Information - Narrative (Details) - Revenue from contract with customer benchmark - Customer Concentration Risk	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Customer One
Concentration Risk [Line Items]
Percentage of revenue (as percent)	28%	52%
Customer Two
Concentration Risk [Line Items]
Percentage of revenue (as percent)	24%	23%

Subsequent Events - Narrative (

Subsequent Events - Narrative (Details) - Subsequent Event - Class A Common Stock - USD ($) $ in Millions	May 09, 2023	May 08, 2023
Subsequent Event [Line Items]
Sale of stock, shares issued in transaction		1,652,892
Sale of stock, gross proceeds		$ 10
Granted (in shares)	1,652,892
Option to purchase additional shares granted amount	$ 10
Award expiration period (in days)	90 days